- Report
- June 2025
- 137 Pages
United States
From €5370EUR$5,950USD£4,665GBP
- Report
- February 2026
- 75 Pages
Europe
From €2933EUR$3,250USD£2,548GBP
- Report
- February 2026
- 68 Pages
Asia Pacific
From €2933EUR$3,250USD£2,548GBP
- Report
- February 2026
- 57 Pages
Asia Pacific
From €2933EUR$3,250USD£2,548GBP
- Report
- February 2026
- 70 Pages
Europe
From €2933EUR$3,250USD£2,548GBP
- Report
- December 2025
- 81 Pages
Europe
From €2933EUR$3,250USD£2,548GBP
- Report
- December 2025
- 71 Pages
Asia Pacific
From €2933EUR$3,250USD£2,548GBP
- Report
- May 2025
- 85 Pages
United States
From €3159EUR$3,500USD£2,744GBP
- Report
- April 2025
- 162 Pages
Europe
From €3113EUR$3,450USD£2,705GBP
- Report
- April 2025
- 163 Pages
Asia Pacific
From €3113EUR$3,450USD£2,705GBP
- Report
- April 2025
- 146 Pages
North America
From €3113EUR$3,450USD£2,705GBP
- Report
- April 2025
- 153 Pages
Africa, Middle East
From €3113EUR$3,450USD£2,705GBP
- Report
- September 2025
- 163 Pages
Middle East, Africa
From €1354EUR$1,500USD£1,176GBP
- Report
- October 2025
- 51 Pages
Asia Pacific
From €2933EUR$3,250USD£2,548GBP
- Report
- October 2025
- 58 Pages
Europe
From €2933EUR$3,250USD£2,548GBP
- Report
- October 2025
- 80 Pages
Middle East
From €4377EUR$4,850USD£3,803GBP
- Report
- October 2025
- 97 Pages
Asia Pacific
From €4377EUR$4,850USD£3,803GBP
- Report
- October 2025
- 100 Pages
Middle East
From €4377EUR$4,850USD£3,803GBP
- Report
- October 2025
- 84 Pages
United States
From €4377EUR$4,850USD£3,803GBP
- Report
- June 2024
- 299 Pages
Global
From €5182EUR$5,943USD£4,350GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more